TrialEuropean urology2015
Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony).
Paul Abrams et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
72 papers cite itlatest 60 shown
this paperpooled ittrialcites it